SCHEMBL13763843

SCHEMBL13763843

N#Cc1ccc(-n2nnc3cnc(Nc4cccc(C(N)=O)c4)nc32)cc1OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3A P49840 6/20 0.47
▸ GSK3B P49841 6/20 0.47
▸ AURKA O14965 4/20 0.47
▸ EGFR P00533 1/20 0.41
▸ ERBB2 P04626 1/20 0.41
▸ PPIA P62937 1/20 0.41
▸ EIF2AK4 Q9P2K8 1/20 0.39
▸ XDH P47989 1/20 0.38
▸ USP2 O75604 3/20 0.37
▸ CYP3A4 P08684 3/20 0.37
▸ TSHR P16473 2/20 0.37
▸ CASP1 P29466 2/20 0.37
▸ CASP7 P55210 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ BRCA1 P38398 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ SYK P43405 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8297919 0.81 GSK3A (0.69) GSK3AGSK3BAURKAEGFREIF2AK4
SCHEMBL13763823 0.81 GSK3A (0.62) GSK3AGSK3BAURKAEGFREIF2AK4
SCHEMBL5039537 0.77 EGFR (0.48) EGFRERBB2PPIASYK
SCHEMBL13763827 0.75 GSK3A (0.47) GSK3AGSK3BAURKAEGFRUSP2
SCHEMBL13925826 0.75 PPIA (0.41) EGFRERBB2PPIAXDHSYK
SCHEMBL13763921 0.74 GSK3A (0.59) GSK3AGSK3BAURKAEGFREIF2AK4
SCHEMBL13764047 0.74 GSK3A (0.59) GSK3AGSK3BAURKAEGFREIF2AK4
SCHEMBL13303718 0.74 GSK3A (0.67) GSK3AGSK3BAURKAEGFREIF2AK4
SCHEMBL13764010 0.74 GSK3B (0.79) GSK3AGSK3BAURKAEGFREIF2AK4
SCHEMBL13763871 0.74 AURKA (0.78) GSK3AGSK3BAURKAEGFREIF2AK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7560458-B2 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors JANSSEN PHARMACEUTICA, N.V. (BE) 2009-07-14 — — US disclosed
US-7560458-B2 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors JANSSEN PHARMACEUTICA, N.V. (BE) 2009-07-14 — — US disclosed
Send feedback